Credit Suisse’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$425K Buy
+156,700
New +$425K ﹤0.01% 2700
2022
Q2
Sell
-68,392
Closed -$245K 4119
2022
Q1
$245K Sell
68,392
-970
-1% -$3.48K ﹤0.01% 3290
2021
Q4
$272K Buy
69,362
+5,855
+9% +$23K ﹤0.01% 3336
2021
Q3
$418K Buy
63,507
+4,767
+8% +$31.4K ﹤0.01% 3100
2021
Q2
$362K Sell
58,740
-17,122
-23% -$106K ﹤0.01% 3185
2021
Q1
$342K Sell
75,862
-9,691
-11% -$43.7K ﹤0.01% 3119
2020
Q4
$513K Buy
+85,553
New +$513K ﹤0.01% 2966
2020
Q3
Sell
-10,578
Closed -$43K 3275
2020
Q2
$43K Sell
10,578
-88,226
-89% -$359K ﹤0.01% 3230
2020
Q1
$250K Buy
98,804
+66,372
+205% +$168K ﹤0.01% 2929
2019
Q4
$113K Sell
32,432
-11,767
-27% -$41K ﹤0.01% 3388
2019
Q3
$204K Sell
44,199
-71,843
-62% -$332K ﹤0.01% 3189
2019
Q2
$1.43M Buy
+116,042
New +$1.43M ﹤0.01% 2128
2018
Q2
Sell
-15,316
Closed -$89K 3540
2018
Q1
$89K Buy
15,316
+2,292
+18% +$13.3K ﹤0.01% 3389
2017
Q4
$76K Sell
13,024
-7,027
-35% -$41K ﹤0.01% 3372
2017
Q3
$100K Buy
+20,051
New +$100K ﹤0.01% 3602
2017
Q1
Sell
-11,365
Closed -$83K 3519
2016
Q4
$83K Sell
11,365
-22,247
-66% -$162K ﹤0.01% 3616
2016
Q3
$269K Sell
33,612
-239
-0.7% -$1.91K ﹤0.01% 3353
2016
Q2
$306K Sell
33,851
-34,669
-51% -$313K ﹤0.01% 3378
2016
Q1
$553K Buy
68,520
+45,108
+193% +$364K ﹤0.01% 2886
2015
Q4
$253K Sell
23,412
-39,240
-63% -$424K ﹤0.01% 3556
2015
Q3
$507K Sell
62,652
-7,219
-10% -$58.4K ﹤0.01% 3176
2015
Q2
$1.69M Buy
69,871
+28,639
+69% +$693K ﹤0.01% 2460
2015
Q1
$1.74M Buy
41,232
+21,148
+105% +$890K ﹤0.01% 2274
2014
Q4
$677K Sell
20,084
-50,356
-71% -$1.7M ﹤0.01% 3128
2014
Q3
$1.73M Sell
70,440
-43,315
-38% -$1.06M ﹤0.01% 2268
2014
Q2
$3.35M Buy
113,755
+58,569
+106% +$1.72M ﹤0.01% 1974
2014
Q1
$2.43M Buy
55,186
+6,068
+12% +$267K ﹤0.01% 2082
2013
Q4
$1.88M Buy
49,118
+34,604
+238% +$1.33M ﹤0.01% 2341
2013
Q3
$318K Sell
14,514
-6,632
-31% -$145K ﹤0.01% 3342
2013
Q2
$369K Buy
+21,146
New +$369K ﹤0.01% 3111